Register for free to listen to this article
Listen with Speechify
0:00
1:00
CAMBRIDGE, England—Linguamatics Ltd., a provider of enterprise text mining for life science researchers, announced in June that it has joined the Microsoft BioIT Alliance, an association of life science organizations and informatics companies whose focus is to enhance collaboration and accelerate the pace of drug discovery and development.

"As the amount of textual information impacting drug discovery and development programs grows exponentially each year, the ability to extract and share decision-relevant knowledge is crucial to streamline the process and raise productivity," says Linguamatics COO and Co-Founder Roger Hale. "Linguamatics is delighted to be part of Microsoft's BioIT Alliance. As a leader in knowledge discovery from text, we look forward to working with other alliance members to explore new ways in which the immense value of text mining can be exploited across complex, multi-disciplinary organizations like pharmaceutical companies."

Formed in 2006, the BioIT Alliance is a cross-industry group whose founding members include Accelrys Software Inc., Affymetrix Inc., Agilent Technologies Inc., Amylin Pharmaceuticals Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corp., Geospiza Inc., Hewlett-Packard Development Co. L.P., Illumina Inc., InterKnowlogy, Microsoft Corp., Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. DDN

Related Topics

Published In

Volume 4 - Issue 7 | July 2008

July 2008

July 2008 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue